Stuart Poulton
Corporate Officer/Principal at KARYOPHARM THERAPEUTICS INC.
Net worth: 38 926 $ as of 29/04/2024
Profile
Stuart Poulton is currently the Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. Prior to his current position, he worked as the Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016.
He also held the position of Head-Clinical Operations at Eli Lilly & Co. Additionally, Mr. Poulton served as the Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022.
He completed his graduate degree at The University of New South Wales and his undergraduate degree at The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/03/2024 | 36,723 ( 0.03% ) | 38 926 $ | 29/04/2024 |
Stuart Poulton active positions
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 31/01/2022 |
Former positions of Stuart Poulton
| Companies | Position | End |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 31/12/2021 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2015 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Stuart Poulton
| The University of Sydney | Undergraduate Degree |
| The University of New South Wales | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
- Stock Market
- Insiders
- Stuart Poulton
